These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Huntington's disease: current concepts of therapy. Goetz CG; Weiner WJ J Am Geriatr Soc; 1979 Jan; 27(1):23-6. PubMed ID: 153351 [TBL] [Abstract][Full Text] [Related]
7. Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine. Brusa L; Orlacchio A; Moschella V; Iani C; Bernardi G; Mercuri NB Mov Disord; 2009 Jan; 24(1):126-9. PubMed ID: 19170197 [TBL] [Abstract][Full Text] [Related]
8. Ziprasidone (Geodon) for schizophrenia. Med Lett Drugs Ther; 2001 Jun; 43(1106):51-2. PubMed ID: 11402259 [No Abstract] [Full Text] [Related]
9. Pharmacologic approaches to the treatment of Huntington's disease. Venuto CS; McGarry A; Ma Q; Kieburtz K Mov Disord; 2012 Jan; 27(1):31-41. PubMed ID: 21997232 [TBL] [Abstract][Full Text] [Related]
10. Acute psychosis in a verified Huntington disease gene carrier with subtle motor signs: psychiatric criteria should be considered for the diagnosis. Nagel M; Rumpf HJ; Kasten M Gen Hosp Psychiatry; 2014; 36(3):361.e3-4. PubMed ID: 24576988 [TBL] [Abstract][Full Text] [Related]
11. Focus on ziprasidone. Green B Curr Med Res Opin; 2001; 17(2):146-50. PubMed ID: 11759185 [TBL] [Abstract][Full Text] [Related]
12. Clinical experience with risperidone and memantine in the treatment of Huntington's disease. Cankurtaran ES; Ozalp E; Soygur H; Cakir A J Natl Med Assoc; 2006 Aug; 98(8):1353-5. PubMed ID: 16916137 [TBL] [Abstract][Full Text] [Related]
13. Acute-phase proteins in relation to neuropsychiatric symptoms and use of psychotropic medication in Huntington's disease. Bouwens JA; Hubers AA; van Duijn E; Cobbaert CM; Roos RA; van der Mast RC; Giltay EJ Eur Neuropsychopharmacol; 2014 Aug; 24(8):1248-56. PubMed ID: 24957738 [TBL] [Abstract][Full Text] [Related]